These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26313662)

  • 1. HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.
    Thuring C; Follin E; Geironson L; Freyhult E; Junghans V; Harndahl M; Buus S; Paulsson KM
    Br J Cancer; 2015 Sep; 113(6):952-62. PubMed ID: 26313662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
    Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
    Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
    Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S
    Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
    Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
    Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tapasin and human leukocyte antigen class I dysregulation correlates with survival in glioblastoma multiforme.
    Thuring C; Geironson L; Paulsson K
    Anticancer Agents Med Chem; 2014; 14(8):1101-9. PubMed ID: 25175688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
    Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
    Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
    Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H
    Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
    Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
    Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
    Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
    Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-I antigen presentation and tapasin influence immune responses against malignant brain tumors - considerations for successful immunotherapy.
    Darabi A; Thuring C; Paulsson KM
    Anticancer Agents Med Chem; 2014; 14(8):1094-100. PubMed ID: 25175689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
    Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
    Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
    Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
    Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing.
    Wu AH; Hall WA; Low WC
    J Neurooncol; 2004 Jan; 66(1-2):1-8. PubMed ID: 15015764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.